Go Back To Menu
Close
- Mailing Form
-
Medical Report*
-
Go Back To Menu
Thyroid cancer is a malignant tumor originating from follicular or C cells of the thyroid gland. It is commonly seen in young women but may also affect the elderly. Most patients show no obvious symptoms in the early stages and often seek medical advice after discovering a neck mass during physical examination. Thyroid cancer has multiple types, the most common being papillary carcinoma, follicular carcinoma, medullary carcinoma, and anaplastic carcinoma. Papillary carcinoma is the most frequent and has a relatively favorable prognosis.
The incidence of thyroid cancer is increasing annually worldwide, particularly in North America, South Korea, and Japan. Southeast Asian regions such as China, Singapore, and Vietnam have also reported a gradual rise. This increasing trend is closely associated with the widespread use of imaging examinations.
1. Local Compression Symptoms
As the tumor grows, it may compress the trachea and esophagus, leading to breathing difficulties, swallowing discomfort, or hoarseness, thereby affecting patients’ quality of daily life.
2. High Risk of Metastasis
Certain types, such as follicular carcinoma and anaplastic carcinoma, are highly invasive and prone to metastasis, spreading through lymphatic or blood circulation to distant organs such as the lungs and bones.
3. Risk of Postoperative Recurrence
Even after surgical resection, some patients may still experience recurrence within a few years, especially if the extent of the lesion was not fully assessed before surgery, which increases the risk of relapse.
4. Impact on Endocrine Function
After thyroid removal, lifelong thyroid hormone replacement therapy is required. Poor control may lead to metabolic disorders or cardiovascular complications.
Immune reconstruction cell therapy works by activating the patient’s own immune system to identify and eliminate residual cancer cells, improving postoperative control rates and reducing recurrence risk. This therapy has shown potential in various tumors and has also achieved positive outcomes in thyroid cancer, particularly in patients with high recurrence risk or poor response to conventional treatments.
In actual treatment, cancer patients undergoing surgery, radiotherapy, or chemotherapy often face immune function impairment, increased infection risk, and slow recovery. To help patients better endure the treatment process and improve their tolerance and quality of life, it is necessary to scientifically formulate phased immune reconstruction programs for different treatment cycles.
● Short-term plan: Rapidly enhance immunity through immune cell reinfusion to boost the effectiveness of anti-cancer treatment.
● Mid-term plan: Reduce the side effects of conventional treatments, promote recovery, and ensure completion of standardized therapy.
● Long-term plan: Strengthen overall immunity through immune cell reconstruction, intestinal immune rebuilding, elemental immune reconstruction, and immune nutritional support, thereby improving quality of life and prolonging survival.
1. Surgery as the Fundamental Method
Surgical removal is the primary treatment for thyroid cancer, including partial or total thyroidectomy, often accompanied by cervical lymph node dissection. For early-stage papillary carcinoma, unilateral resection is usually sufficient.
2. Radioactive Iodine Therapy
Radioactive iodine (I-131) is often used as adjuvant therapy post-surgery to eliminate residual thyroid tissue or metastases, particularly effective in papillary and follicular carcinoma.
3. Molecular Targeted Therapy
For advanced or recurrent patients, targeted drugs such as multi-target tyrosine kinase inhibitors (TKIs) can slow disease progression and are often applied to patients who cannot undergo surgery or are resistant to iodine therapy.
4. Minimally Invasive Interventional Therapy
Some early-stage cases or patients unsuitable for surgery may choose minimally invasive approaches such as percutaneous radiofrequency ablation or laser ablation. These methods are simple, less invasive, and increasingly recognized.
Although thyroid cancer is often of low malignancy, its long-term health impact should not be underestimated. Standardized and proactive treatment is the key to preventing recurrence. Experts at United Life International Medical Center emphasize that timely detection and effective treatment strategies can greatly improve both survival quality and life expectancy.
